U.S. markets closed

Top Ranked Momentum Stocks to Buy for April 22nd

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 22nd:

Ardmore Shipping Corporation (ASC): This company engaged in the seaborne transportation of petroleum products and chemicals has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.5% over the last 60 days.

Ardmore Shipping Corporation Price and Consensus

Ardmore Shipping Corporation Price and Consensus

Ardmore Shipping Corporation price-consensus-chart | Ardmore Shipping Corporation Quote

Ardmore Shipping’s shares gained 45.7% over the last one month above the S&P 500’s increase of 21.3%. The company possesses a Momentum Score of B.

Ardmore Shipping Corporation Price

Ardmore Shipping Corporation Price

Ardmore Shipping Corporation price | Ardmore Shipping Corporation Quote

CorMedix, Inc. (CRMD): This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.

CorMedix Inc Price and Consensus

CorMedix Inc Price and Consensus

CorMedix Inc price-consensus-chart | CorMedix Inc Quote

CorMedix’s shares gained 48.5% over the last one month. The company possesses a Momentum Score of B.

CorMedix Inc Price

CorMedix Inc Price

CorMedix Inc price | CorMedix Inc Quote

Arcimoto, Inc. (FUV): This manufacturer of three-wheeled electric vehicles has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.1% over the last 60 days.

Arcimoto, Inc. Price and Consensus

Arcimoto, Inc. Price and Consensus

Arcimoto, Inc. price-consensus-chart | Arcimoto, Inc. Quote

Arcimoto’s shares gained 27.6% over the last one month. The company possesses a Momentum Score of B.

Arcimoto, Inc. Price

Arcimoto, Inc. Price

Arcimoto, Inc. price | Arcimoto, Inc. Quote

Ovid Therapeutics Inc. (OVID): This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.4% over the last 60 days.

OVID THERAPEUTC Price and Consensus

OVID THERAPEUTC Price and Consensus

OVID THERAPEUTC price-consensus-chart | OVID THERAPEUTC Quote

Ovid Therapeutics’ shares gained 38.9% over the last one month. The company possesses a Momentum Score of B.

OVID THERAPEUTC Price

OVID THERAPEUTC Price

OVID THERAPEUTC price | OVID THERAPEUTC Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>                  


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
OVID THERAPEUTC (OVID) : Free Stock Analysis Report
 
Arcimoto, Inc. (FUV) : Free Stock Analysis Report
 
CorMedix Inc (CRMD) : Free Stock Analysis Report
 
Ardmore Shipping Corporation (ASC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.